Invasive Trichoderma spp. infections: clinical presentation and
outcome of cases from the literature and the FungiScope(R)
registry

J 2022

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry

SAL, Ertan, Jannik STEMLER, Jon SALMANTON-GARCIA, Iker FALCES-ROMERO, Laszlo KREDICS et. al.

Basic information

Original name

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry

Authors

SAL, Ertan, Jannik STEMLER, Jon SALMANTON-GARCIA, Iker FALCES-ROMERO, Laszlo KREDICS, Elisabeth MEYER, Benjamin WUERSTL, Cornelia LASS-FLOERL, Zdeněk RÁČIL (203 Czech Republic, belonging to the institution), Nikolay KLIMKO, Simone CESARO, Anupma Jyoti KINDO, Hilmar WISPLINGHOFF, Philipp KOEHLER, Oliver A. CORNELY and Danila SEIDEL (guarantor)

Edition

Journal of Antimicrobial Chemotherapy, OXFORD, Oxford University Press, 2022, 0305-7453

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 5.200

RIV identification code

RIV/00216224:14110/22:00126680

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1093/jac/dkac235

UT WoS

000836090400001

Keywords in English

Invasive Trichoderma spp. infections

Abstract

V originále

Background Trichoderma spp. are filamentous fungi causing invasive fungal diseases in patients with haematological malignancies and in peritoneal dialysis patients. Objectives To analyse clinical presentation, predisposing factors, treatment and outcome of Trichoderma infections. Methods A systematic literature review was conducted for published cases of invasive Trichoderma infection in PubMed until December 2021 and by reviewing the included studies' references. Cases from the FungiScope(R) registry were added to a combined analysis. Results We identified 50 invasive infections due to Trichoderma species, including 11 in the FungiScope(R) registry. The main underlying conditions were haematological malignancies in 19 and continuous ambulatory peritoneal dialysis (CAPD) in 10 cases. The most prevalent infection sites were lung (42%) and peritoneum (22%). Systemic antifungal therapy was administered in 42 cases (84%), mostly amphotericin B (n = 27, lipid-based formulation 13/27) and voriconazole in 15 cases (30%). Surgical interventions were performed in 13 cases (26%). Overall mortality was 48% (n = 24) and highest for allogeneic HSCT and solid organ transplantation (SOT) recipients [80% (4/5) and 77% (7/9), respectively]. In patients treated with amphotericin B, voriconazole and caspofungin, mortality was 55% (15/27), 46% (7/15) and 28% (2/7), respectively. Three out of four patients treated with a combination therapy of voriconazole and caspofungin survived. Conclusions Despite treatment with antifungal therapies and surgery, invasive Trichoderma infections are life-threatening complications in immunocompromised patients, especially after HSCT and SOT. In addition, Trichoderma spp. mainly affect the lungs in patients with haematological malignancies and the peritoneum in CAPD patients.

Citovat

SAL, Ertan, Jannik STEMLER, Jon SALMANTON-GARCIA, Iker FALCES-ROMERO, Laszlo KREDICS, Elisabeth MEYER, Benjamin WUERSTL, Cornelia LASS-FLOERL, Zdeněk RÁČIL, Nikolay KLIMKO, Simone CESARO, Anupma Jyoti KINDO, Hilmar WISPLINGHOFF, Philipp KOEHLER, Oliver A. CORNELY and Danila SEIDEL. Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry. Journal of Antimicrobial Chemotherapy. OXFORD: Oxford University Press, 2022, vol. 77, No 10, p. 2850-2858. ISSN 0305-7453. Available from: https://dx.doi.org/10.1093/jac/dkac235.

@article{2217990,
   author = {Sal, Ertan and Stemler, Jannik and SalmantonandGarcia, Jon and FalcesandRomero, Iker and Kredics, Laszlo and Meyer, Elisabeth and Wuerstl, Benjamin and LassandFloerl, Cornelia and Ráčil, Zdeněk and Klimko, Nikolay and Cesaro, Simone and Kindo, Anupma Jyoti and Wisplinghoff, Hilmar and Koehler, Philipp and Cornely, Oliver A. and Seidel, Danila},
   article_location = {OXFORD},
   article_number = {10},
   doi = {http://dx.doi.org/10.1093/jac/dkac235},
   keywords = {Invasive Trichoderma spp. infections},
   language = {eng},
   issn = {0305-7453},
   journal = {Journal of Antimicrobial Chemotherapy},
   title = {Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry},
   url = {https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkac235/6656053?login=true},
   volume = {77},
   year = {2022}
}

TY  - JOUR
ID  - 2217990
AU  - Sal, Ertan - Stemler, Jannik - Salmanton-Garcia, Jon - Falces-Romero, Iker - Kredics, Laszlo - Meyer, Elisabeth - Wuerstl, Benjamin - Lass-Floerl, Cornelia - Ráčil, Zdeněk - Klimko, Nikolay - Cesaro, Simone - Kindo, Anupma Jyoti - Wisplinghoff, Hilmar - Koehler, Philipp - Cornely, Oliver A. - Seidel, Danila
PY  - 2022
TI  - Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry
JF  - Journal of Antimicrobial Chemotherapy
VL  - 77
IS  - 10
SP  - 2850-2858
EP  - 2850-2858
PB  - Oxford University Press
SN  - 03057453
KW  - Invasive Trichoderma spp. infections
UR  - https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkac235/6656053?login=true
N2  - Background Trichoderma spp. are filamentous fungi causing invasive fungal diseases in patients with haematological malignancies and in peritoneal dialysis patients. Objectives To analyse clinical presentation, predisposing factors, treatment and outcome of Trichoderma infections. Methods A systematic literature review was conducted for published cases of invasive Trichoderma infection in PubMed until December 2021 and by reviewing the included studies' references. Cases from the FungiScope(R) registry were added to a combined analysis. Results We identified 50 invasive infections due to Trichoderma species, including 11 in the FungiScope(R) registry. The main underlying conditions were haematological malignancies in 19 and continuous ambulatory peritoneal dialysis (CAPD) in 10 cases. The most prevalent infection sites were lung (42%) and peritoneum (22%). Systemic antifungal therapy was administered in 42 cases (84%), mostly amphotericin B (n = 27, lipid-based formulation 13/27) and voriconazole in 15 cases (30%). Surgical interventions were performed in 13 cases (26%). Overall mortality was 48% (n = 24) and highest for allogeneic HSCT and solid organ transplantation (SOT) recipients [80% (4/5) and 77% (7/9), respectively]. In patients treated with amphotericin B, voriconazole and caspofungin, mortality was 55% (15/27), 46% (7/15) and 28% (2/7), respectively. Three out of four patients treated with a combination therapy of voriconazole and caspofungin survived. Conclusions Despite treatment with antifungal therapies and surgery, invasive Trichoderma infections are life-threatening complications in immunocompromised patients, especially after HSCT and SOT. In addition, Trichoderma spp. mainly affect the lungs in patients with haematological malignancies and the peritoneum in CAPD patients.
ER  -

SAL, Ertan, Jannik STEMLER, Jon SALMANTON-GARCIA, Iker FALCES-ROMERO, Laszlo KREDICS, Elisabeth MEYER, Benjamin WUERSTL, Cornelia LASS-FLOERL, Zdeněk RÁČIL, Nikolay KLIMKO, Simone CESARO, Anupma Jyoti KINDO, Hilmar WISPLINGHOFF, Philipp KOEHLER, Oliver A. CORNELY and Danila SEIDEL. Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(R) registry. \textit{Journal of Antimicrobial Chemotherapy}. OXFORD: Oxford University Press, 2022, vol.~77, No~10, p.~2850-2858. ISSN~0305-7453. Available from: https://dx.doi.org/10.1093/jac/dkac235.

Detailed Information on Publication Record